Sanofi To Invest 400 Million Euros In A mRNA Vaccines Center

INSUBCONTINENT EXCLUSIVE:
to help Pfizer and Moderna manufacture COVID-19 shots in an effort to help meet the huge demand for the United States drugmaker's
vaccine response to COVID-19, including in response to the virus' variants.The latest one, the Delta variant first found in India, is
spreading at a fast rate around the world, prompting governments to accelerate their vaccinations programs.French Health Minister Oliver
vaccine candidate with United States company Translate Bio, for which it has started clinical trials.The two groups, which have been
used against the human papillomavirus, hepatitis B and pertussis among other pathogens - which aims to introduce lab-made proteins into the
body to prod the immune system into developing a targeted defence against the novel coronavirus.